Enimmune Corporation (TPEX:6564)
16.15
+0.05 (0.31%)
Aug 4, 2026, 1:41 PM CST
-2.71% (1Y)
| Market Cap | 1.15B -3.9% |
| Revenue (ttm) | 48.19M +20.7% |
| Net Income | -164.35M |
| EPS | -2.28 |
| Shares Out | 72.13M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 18,519 |
| Open | 16.10 |
| Previous Close | 16.10 |
| Day's Range | 15.55 - 16.15 |
| 52-Week Range | 14.90 - 23.90 |
| Beta | 0.30 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Aug 11, 2026 |